JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
RKT
Rocket Companies, Inc.
RKT has a slight edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
RKT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
RKT's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like RKT.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over RKT in the historical PE scenario, which offers more potential upside but is not a forecast.
RKT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.7x | $0.36 | -97% |
| Fair | 0.9x | $0.47 | -97% |
| Forward | 23x | $13.71 | — |
| Current | 26x | $13.71 | — |
| Expensive | 57x | $30.08 | +119% |
Historical ranges are pointers, not guarantees.
RKT's PE is 26x, but its earnings don't support one, so it isn't a reliable read right now.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
RKT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKT's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
RKT Earnings Per Share
RKT and JPM do not have enough comparable growth data to identify a winner.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over RKT on profitability, with a higher operating margin.
RKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3B | +105% |
| Q2 2026 | $2.8B | +105% |
| Q1 2026 | $2.9B | +184% |
| Q4 2025 | $2.7B | +52% |
| Q3 2025 | $1.6B | +148% |
| Q2 2025 | $1.4B | +4.6% |
| Q1 2025 | $1B | -25% |
| Q4 2024 | $1.8B | +155% |
RKT has the edge over JPM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +41 points |
| Q2 2026 | 10% | +8.3 points |
| Q1 2026 | 14% | +35 points |
| Q4 2025 | 6.3% | -32 points |
| Q3 2025 | -11% | +65 points |
| Q2 2025 | 1.8% | -13 points |
| Q1 2025 | -22% | -43 points |
| Q4 2024 | 38% | +73 points |
RKT's operating margin was 29% last quarter, up 41 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
RKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.9B | +$1.9B |
| Q2 2026 | -$1.2B | +$619.6M |
| Q1 2026 | $1.8B | +$2.6B |
| Q4 2025 | -$1.3B | -170% |
| Q3 2025 | -$71.8M | +$1.3B |
| Q2 2025 | -$1.9B | -$1.7B |
| Q1 2025 | -$811M | +$2.2B |
| Q4 2024 | $1.8B | +31% |
RKT has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over RKT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
RKT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +1.9M shares |
| 1 year | +42% | +842M shares |
| 3 years | +43% | +856M shares |
RKT has 2.8B diluted shares, up 42% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | $11.7M |
| Q3 2022 | $20.6M |
| Q2 2022 | $45.3M |
| Q1 2022 | $100.2M |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over RKT on leverage, with a lower net debt burden relative to earnings.
RKT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.3x | Elevated |
| Q2 2026 | 6.4x | High |
| Q1 2026 | 9.5x | High |
| Q4 2025 | 287.9x | High |
| Q3 2025 | 29.1x | High |
| Q2 2025 | 136.0x | High |
| Q1 2025 | 39.5x | High |
| Q4 2024 | 12.1x | High |
RKT's net debt is about 3.3 years of its operating earnings (EBITDA), down from more than 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like RKT.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
RKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.4 | Neutral |
| Stochastic | 72.6 | Neutral |
RKT's weekly RSI is 50 (neutral) and its Stochastic is 73 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over RKT on valuation relative to its sector.
RKT PE vs Financial Services Sector
| Metric | RKT | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 13x | 99% above |
| PE % | 62 | 62 | Same percentile |
RKT is trading at 26x earnings, a 99% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over RKT on trend strength, trading above more of its moving averages.
RKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.4 | 10% above |
| 20 week MA | $13.3 | 3.2% above |
| 50 week MA | $15.3 | 11% below |
| 100 week MA | $15.1 | 9.3% below |
| 200 week MA | $13.6 | 0.9% above |
RKT's trend is mixed: it's above three of its five weekly moving averages, and 0.9% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over RKT on returns for 2026, with the stronger performance.
RKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.9 | $20.8 | -16% |
| 2021 | $20.8 | $15.3 | -27% |
| 2022 | $15.3 | $7.29 | -52% |
| 2023 | $7.29 | $14.5 | +99% |
| 2024 | $14.5 | $11.1 | -23% |
| 2025 | $11.1 | $19.4 | +75% |
| 2026 YTD | $19.4 | $13.7 | -29% |
RKT has finished lower in four of the last six years. It's down 29% so far in 2026.